Skip to main content
# العنوان سنة البحث
331 Enhancement of the anti‐inflammatory and anti‐arthritic effects of theophylline by a low dose of a nitric oxide donor or non‐specific nitric oxide synthase inhibitor 2009
332 The influence of experimental schistosomiasis on the pharmacokinetics and pharmacodynamics of phenobarbital and diphenylhydantoin in mice.
2009
333 Protective Effect of Aminoguanidine Against Cyclosporine induced Nephrotoxicity and Hepatotoxicity in Rats: Histological and Biochemical Study. 2009
334 Enhancement of the anti‐inflammatory and anti‐arthritic effects of theophylline by a low dose of a nitric oxide donor or non‐specific nitric oxide synthase inhibitor 2009
335 The influence of experimental schistosomiasis on the pharmacokinetics and pharmacodynamics of phenobarbital and diphenylhydantoin in mice.
2009
336 The risk of asymptomatic hyperammonemia in children with idiopathic epilepsy treated with valproate: Relationship to blood carnitine status. 2009
337 Estimation of lithium clearance from routine clinical data in Egyptian bipolar patients. A population pharmacokinetic approach.
2008
338 The potential protective role of alpha-lipoic acid against acetaminophen- induced Hepatic and renal damage 2008
339 Pegylated polybutylcyanoacrylate nanoparticles as a vector for enhancement of baclofen delivery through blood-brain barrier. 2008
340 5-(4-Chlorophenyl)-5,6-dihydro-1,3-oxazepin-7(4H)-one derivatives as lipophilic cyclic analogues of baclofen: Design, synthesis, and neuropharmacological evaluation. 2008